title: Myometrial response to neurotropic and musculotropic spasmolytic drugs in an extracorporeal perfusion model of swine uteri.
abstract: To compare the effects of neurotropic and musculotropic spasmolytic drugs in isolated swine uterus specimens, 80 swine uteri were perfused using an established model for preserving a viable organ that responds to oxytocic hormones and spasmolytic drugs. An intrauterine catheter was used to record pressure changes. Following initiation of rhythmic uterine contractions and recording of spontaneous rhythmic contractions, spasmolytic drugs (butylscopolamine, atropine, denaverine, morphine, metamizole, pethidine and celandine) were administered at various concentrations. The musculotropic relaxant denaverine in particular showed significant results (P ≤ 0.05) for all dosages and parameters investigated. In terms of muscle physiology, musculotropic agents (denaverine and celandine) have clear advantages in comparison with neurotropic (butylscopolamine and atropine) or musculoneurotropic (morphine, metamizole and pethidine) spasmolytic drugs for inhibiting contractions. Experiments with pethidine (Dolantin) also showed promising results; with celandine (Paverysat), an initial increase in contractions was observed that may suggest ways of promoting rapid directed sperm transport. Denaverine and pethidine in particular may in the future be able to play an important role in improving the pregnancy rate after IVF.
authors.affiliation: Department of Gynaecology, Erlangen University Hospital, Erlangen, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Künzel
authors.forename: K
authors.initials: K
authors.lastname: Geisler
authors.forename: I
authors.initials: I
authors.lastname: Hoffmann
authors.forename: A
authors.initials: A
authors.lastname: Müller
authors.forename: M W
authors.initials: MW
authors.lastname: Beckmann
authors.forename: R
authors.initials: R
authors.lastname: Dittrich
mesh_terms: D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001561:Benzilates / Q000494:pharmacology; D002086:Butylscopolammonium Bromide / Q000494:pharmacology; D028281:Chelidonium; D004177:Dipyrone / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D008614:Meperidine / Q000494:pharmacology; D023421:Models, Animal; D009020:Morphine / Q000494:pharmacology; D009215:Myometrium / Q000187:drug effects* / Q000502:physiology; D010276:Parasympatholytics / Q000494:pharmacology*; D010936:Plant Extracts / Q000494:pharmacology*; D013552:Swine; D014590:Uterine Contraction / Q000187:drug effects* / Q000502:physiology; D014599:Uterus / Q000187:drug effects* / Q000502:physiology
chemical_list: D001561:Benzilates; D010276:Parasympatholytics; D010936:Plant Extracts; D002086:Butylscopolammonium Bromide; D004177:Dipyrone; D009020:Morphine; D001285:Atropine; D008614:Meperidine; C001967:denaverine